US rates have been drifting higher over the past week mainly because stronger economic data and the run‑up to the Fed’s December meeting are pushing investors to price in fewer or later rate cuts, which lifts Treasury yields and market borrowing costs.…
Wall Street spent Tuesday marking time and watching the clock, as markets drifted in tight formation ahead of Wednesday’s Fed decision, with just enough sector rotation and deal drama to keep traders from checking out entirely.
Indexes and macro tone
The major…
Microsoft’s latest investment wave is rolling eastward — and this time, it’s not the Nordics reaping the cloud bounty but India, now the company’s fastest-growing market outside the United States. The tech giant is earmarking $17.5 billion to expand data centers, AI…
Traders on Wall Street like to pretend they are focused on the “decision,” but this week the 25 basis points are just the opening act; the real drama arrives in the footnotes, charts, and carefully hedged adverbs of the Fed’s 2026 guidance.…
For much of the post-pandemic era, the American job market was powered by swagger. Workers hopped jobs, demanded signing bonuses, and treated two-week notices like optional courtesies. But as autumn set in, the swagger dimmed.
Layoffs rose to 1.85 million in October,…
Donald Trump’s decision to let Nvidia resume selling advanced chips to China turns export controls into a new form of dealmaking, one that blends national security with revenue sharing. It also tests how far he is willing to go in using America’s…
Wall Street opened the week in a cautious mood Monday, with the major averages edging lower as investors stared down a data‑thin calendar and a Fed meeting that promises more intrigue than drama. The Dow Jones Industrial Average slipped around six‑tenths of…
GeoVax’s (NASDAQ: GOVX) latest cameo in JCO Oncology Advances reads like the opening argument for an oncology re-rate, with its gene-directed cancer therapy Gedeptin now backed by human data that suggest the platform is more than clever lab work. For a company many investors…
IBM is reportedly once again reaching for its M&A checkbook, this time circling data-streaming specialist Confluent in what would be an roughly $11 billion deal, seemingly signaling that “Big Blue” has fully embraced the idea that if you can’t build the cloud-and-AI…
Earlier this week, Milan’s catwalks may have tilted on their axis as Prada S.p.A. closed a deal to acquire Versace for a cool $1.375 billion, marking one of the most ambitious consolidations in the history of Italian couture — a marriage of…
